Cited by 275Diabetes Treatment and ManagementRegulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α

Open access

Freeland, Kristin R., Wolever, Thomas M. S.·2010·British Journal of Nutrition

DOI 10.1017/s0007114509991863

Open this paper in CoChat — free account Open PDF

Abstract

In animals, colonic infusion of SCFA does not affect glucagon-like peptide-1 (GLP-1) release whereas intravenous infusion does and SCFA may directly stimulate peptide YY (PYY) release. It is unknown whether SCFA and their route of administration affect human blood concentrations of GLP-1 and PYY. Our aim was to conduct a pilot study to determine the effects of intravenous and rectal acetate on blood concentrations of GLP-1, PYY, ghrelin, adiponectin and TNF-α in hyperinsulinaemic human subjects. Six hyperinsulinaemic female subjects were given 20 mmol sodium acetate intravenously, 60 mmol acetate rectally, or normal saline rectally or intravenously on four separate occasions in randomised order, with blood samples collected at 0, 10, 15, 30, 45 and 60 min. Change in plasma PYY was significantly higher after acetate and rectal infusions (9·69 and 13·78 pg/ml) compared with saline and intravenous (0·60 and − 3·1 pg/ml; P < 0·01), respectively. Change in plasma GLP-1 was increased by rectal and acetate infusions (0·25 and 0·23 mmol/l) v. intravenous and saline ( − 0·26 and − 0·19 mmol/l; P < 0·01). Acetate decreased TNF-α v. saline ( − 0·8 and 0·15 pg/ml; P < 0·05). Rectal infusions increased TNF-α and ghrelin (0·2 and 98·27 pg/ml) v. intravenous ( − 0·9 and − 40 pg/ml; P < 0·01). There was no effect of treatment on plasma adiponectin. These preliminary results suggest that acetate raises plasma PYY and GLP-1, and suppresses TNF-α. Also, distending the rectum increases PYY, GLP-1, TNF-α and ghrelin in hyperinsulinaemic females. Increasing colonic fermentation products, particularly acetate, could yield a new mechanism for modifying weight gain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1017/s0007114509991863

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard, J., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J., & Fève, B. (2006) · PubMed · Cited by 2,090
Ghrelin, a Novel Growth Hormone-Releasing Acylated Peptide, Is Synthesized in a Distinct Endocrine Cell Type in the Gastrointestinal Tracts of Rats and Humans
Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M. S., Suganuma, T., Matsukura, S., Kangawa, K., & Nakazato, M. (2000) · Endocrinology · doi:10.1210/endo.141.11.7757 · Cited by 1,916
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604
Dietary Fiber, Glycemic Load, and Risk of NIDDM in Men
Salmerón, J., Ascherio, A., Rimm, E. B., Colditz, G. A., Spiegelman, D., Jenkins, D. J., Stampfer, M. J., Wing, A. L., & Willett, W. C. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.545 · Cited by 1,426
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402
Carbohydrates, dietary fiber, and incident type 2 diabetes in older women
Meyer, K. A., Kushi, L. H., Jacobs, D. R., Slavin, J., Sellers, T. A., & Folsom, A. R. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.921 · Cited by 1,271
Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study
Liu, S., Stampfer, M. J., Hu, F. B., Giovannucci, E., Rimm, E., Manson, J. E., Hennekens, C. H., & Willett, W. C. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.412 · Cited by 774
Dietary Fiber, Weight Gain, and Cardiovascular Disease Risk Factors in Young Adults
Ludwig, D. S. (1999) · JAMA · doi:10.1001/jama.282.16.1539 · Cited by 717

Show all 41 references

Research works printed but not linked: 1

Wolever, 1988, Serum short chain fatty acids after rectal infusion of acetate and propionate in man, J Clin Nutr Gastroenterol, 3, 42

Sorted by citations

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Short-chain fatty acids in control of body weight and insulin sensitivity
Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.128 · Cited by 2,298
Gut microbiota in cardiovascular health and disease
Tang, W. H. W., Kitai, T., & Hazen, S. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.309715 · Cited by 1,670
Gut microbial metabolites in obesity, NAFLD and T2DM
Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0156-z · Cited by 1,493
Gut microbiota-derived metabolites as central regulators in metabolic disorders
Agus, A., Clément, K., & Sokol, H. (2021) · Gut · doi:10.1136/gutjnl-2020-323071 · Cited by 1,347
Dietary lipids, gut microbiota and lipid metabolism
Schoeler, M., & Caesar, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09512-0 · Cited by 1,163
Short chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103
Free Fatty Acid Receptors in Health and Disease
Kimura, I., Ichimura, A., Ohue‐Kitano, R., & Igarashi, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00041.2018 · Cited by 1,063
Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis
Portincasa, P., Bonfrate, L., Vacca, M., Angelis, M. D., Farella, I., Lanza, E., Khalil, M., Wang, D. Q. ‐., Sperandio, M., & Ciaula, A. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031105 · Cited by 1,053
Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance
Saad, M. J. A., Santos, A., & Prada, P. O. (2016) · Physiology · doi:10.1152/physiol.00041.2015 · Cited by 836
The role of short-chain fatty acids in immunity, inflammation and metabolism
Yao, Y., Cai, X. T., Fei, W., Ye, Y., Zhao, M., & Zheng, C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1854675 · Cited by 793
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
O’Riordan, K. J., Collins, M., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G. A., Schellekens, H., & Cryan, J. F. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111572 · Cited by 788
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 698
Dietary fibre modulates the gut microbiota
Cronin, P., Joyce, S. A., O’Toole, P. W., & O’Connor, E. M. (2021) · Nutrients · doi:10.3390/nu13051655 · Cited by 658
Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans
Fernandes, J., Su, W., Rahat-Rozenbloom, S., Wolever, T. M. S., & Comelli, E. M. (2014) · Nutrition & Diabetes · doi:10.1038/nutd.2014.23 · Cited by 628
Self-citation
The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity
Hernández, M. A. G., Canfora, E. E., Jocken, J. W. E., & Blaak, E. E. (2019) · Nutrients · doi:10.3390/nu11081943 · Cited by 650
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Beam, A., Clinger, E., & Hao, L. (2021) · Nutrients · doi:10.3390/nu13082795 · Cited by 576
Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders
Gill, P. A., van Zelm, M. C., Muir, J. G., & Gibson, P. R. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14689 · Cited by 520
Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
Ohira, H., Tsutsui, W., & Fujioka, Y. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17006 · Cited by 492
Research progress in the relationship between type 2 diabetes mellitus and intestinal flora
Ma, Q., Li, Y., Li, P., Wang, M., Wang, J., Tang, Z., Wang, T., Luo, L., Wang, C., Wang, T., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109138 · Cited by 443
Interaction Between Obesity and the Gut Microbiota: Relevance in Nutrition
Delzenne, N. M., & Cani, P. D. (2011) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145146 · Cited by 418
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., Barba, C. D., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 455
Short chain fatty acids and their receptors: new metabolic targets
Layden, B. T., Angueira, A. R., Brodsky, M. R., Durai, V., & Lowe, W. L. (2012) · Translational research · doi:10.1016/j.trsl.2012.10.007 · Cited by 366
The gut microbiome as therapeutic target
Cani, P. D., & Delzenne, N. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.012 · Cited by 365
Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
Puddu, A., Sanguineti, R., Montecucco, F., & Viviani, G. L. (2014) · Mediators of Inflammation · doi:10.1155/2014/162021 · Cited by 359
Emergent Sources of Prebiotics: Seaweeds and Microalgae
De Jesus Raposo, M., De Morais, A., & De Morais, R. (2016) · Marine Drugs · doi:10.3390/md14020027 · Cited by 331
Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial
Canfora, E. E., van der Beek, C. M., Jocken, J. W. E., Goossens, G. H., Holst, J. J., Olde Damink, S. W. M., Lenaerts, K., Dejong, C. H. C., & Blaak, E. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-02546-x · Cited by 331
Fecal microbiota transplantation in metabolic syndrome: History, present and future
de Groot, P. F., Frissen, M. N., de Clercq, N. C., & Nieuwdorp, M. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1293224 · Cited by 336
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease
Morris, G., Berk, M., Carvalho, A. F., Caso, J. R., Sanz, Y., Walder, K. R., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 318
The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects
Tarini, J., & Wolever, T. M. S. (2010) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-119 · Cited by 304
Self-citation
Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: a systematic review and meta-analysis
McLoughlin, R. F., Berthon, B. S., Jensen, M. E., Baines, K. J., & Wood, L. G. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.156265 · Cited by 308
Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans
Rahat-Rozenbloom, S., Fernandes, J., Gloor, G. B., & Wolever, T. M. S. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.46 · Cited by 298
Self-citation
Influence of gender and menopausal status on gut microbiota
Santos-Marcos, J. A., Rangel-Zuñiga, O. A., Jimenez-Lucena, R., Quintana-Navarro, G. M., Garcia-Carpintero, S., Malagon, M. M., Landa, B. B., Tena-Sempere, M., Perez-Martinez, P., Lopez-Miranda, J., et al. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.07.008 · Cited by 287
Gut microbiota and GLP-1
Everard, A., & Cani, P. D. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9288-6 · Cited by 279
G-Protein-Coupled Receptors in Intestinal Chemosensation
Reimann, F. M., Tolhurst, G., & Gribble, F. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.019 · Cited by 245
Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men
van der Beek, C. M., Canfora, E. E., Lenaerts, K., Troost, F. J., Olde Damink, S. W. M., Holst, J. J., Masclee, A. A. M., Dejong, C. H. C., & Blaak, E. E. (2016) · Clinical Science · doi:10.1042/cs20160263 · Cited by 230
Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review
Duttaroy, A. K. (2021) · Nutrients · doi:10.3390/nu13010144 · Cited by 239
Modulation of the Gastrointestinal Microbiome with Nondigestible Fermentable Carbohydrates To Improve Human Health
Deehan, E. C., Duar, R. M., Armet, A. M., Pérez-Muñoz, M. E., Jin, M., & Walter, J. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0019-2017 · Cited by 240
Regulation of energy balance by a gut–brain axis and involvement of the gut microbiota
Bauer, P. V., Hamr, S. C., & Duca, F. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2083-z · Cited by 231
GPR43/FFA2: physiopathological relevance and therapeutic prospects
Bindels, L. B., Dewulf, E. M., & Delzenne, N. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.02.002 · Cited by 215
Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host–microbe interactions contributing to obesity
Payne, A. N., Chassard, C., & Lacroix, C. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01009.x · Cited by 204
Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects
Bouter, K. E. C., Bakker, G. J., Levin, E., Hartstra, A. V., Kootte, R. S., Udayappan, S. D., Katiraei, S., Bahler, L., Gilijamse, P. W., Tremaroli, V., et al. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0025-4 · Cited by 208
Interorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jeleník, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 194
Short-Chain Fatty Acid Receptor and Its Contribution to Glucagon-Like Peptide-1 Release
Kaji, I., Karaki, S.-I., & Kuwahara, A. (2014) · Digestion · doi:10.1159/000356211 · Cited by 177
Gut microbiome, endocrine control of gut barrier function and metabolic diseases
Régnier, M., Hul, M. V., Knauf, C., & Cani, P. D. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0473 · Cited by 183
Probiotics as potential biotherapeutics in the management of type 2 diabetes – prospects and perspectives
Panwar, H., Rashmi, H. M., Batish, V. K., & Grover, S. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2376 · Cited by 167
Short-chain fatty acid: An updated review on signaling, metabolism, and therapeutic effects
Rekha, K., Venkidasamy, B., Samynathan, R., Nagella, P., Ребезов, М. Б., Khayrullin, M., Ponomarev, E., Bouyahya, A., Sarkar, T., Shariati, M. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2124231 · Cited by 172
Gut microbiota–derived short-chain fatty acids and kidney diseases
Li, L., Ma, L., & Fu, P. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s150825 · Cited by 164
Influence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance
Carvalho, B. M., & Saad, M. J. A. (2013) · Mediators of Inflammation · doi:10.1155/2013/986734 · Cited by 166
The Infant Gut Microbiome: Evidence for Obesity Risk and Dietary Intervention
Koleva, P. T., Bridgman, S. L., & Kozyrskyj, A. L. (2015) · Nutrients · doi:10.3390/nu7042237 · Cited by 158
Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
Zeng, Y., Wu, Y., Zhang, Q., & Xiao, X. (2023) · mBio · doi:10.1128/mbio.02032-23 · Cited by 180
Consumption of Two Healthy Dietary Patterns Restored Microbiota Dysbiosis in Obese Patients With Metabolic Dysfunction
Haro, C., García‐Carpintero, S., Rangel‐Zúñiga, O. A., Alcalá‐Díaz, J. F., Landa, B. B., Clemente, J. C., Pérez‐Martínez, P., López‐Miranda, J., Pérez‐Jiménez, F., & Camargo, A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700300 · Cited by 149
Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide
Kaji, I., Karaki, S.-I., Tanaka, R., & Kuwahara, A. (2010) · Journal of Molecular Histology · doi:10.1007/s10735-010-9304-4 · Cited by 155
Prebiotic supplementation improves appetite control in children with overweight and obesity: a randomized controlled trial
Hume, M. P., Nicolucci, A. C., & Reimer, R. A. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.140947 · Cited by 147
Effects of dietary fibre on metabolic health and obesity
Deehan, E. C., Mocanu, V., & Madsen, K. L. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00891-z · Cited by 172
The metabolic role of vagal afferent innervation
Waise, T. M. Z., Dranse, H. J., & Lam, T. K. T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0062-1 · Cited by 140
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Esteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133
Involvement of Gut Microbiota, Microbial Metabolites and Interaction with Polyphenol in Host Immunometabolism
Man, A. W. C., Zhou, Y., Xia, N., & Li, H. (2020) · Nutrients · doi:10.3390/nu12103054 · Cited by 138
Protection against the Metabolic Syndrome by Guar Gum-Derived Short-Chain Fatty Acids Depends on Peroxisome Proliferator-Activated Receptor γ and Glucagon-Like Peptide-1
den Besten, G., Gerding, A., van Dijk, T. H., Čiapaitė, J., Bleeker, A., van Eunen, K., Havinga, R., Groen, A. K., Reijngoud, D., & Bakker, B. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136364 · Cited by 128
Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease
Masse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
Covașă, M., Stephens, R. W., Toderean, R., & Cobuz, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00082 · Cited by 117
Increased gut hormones and insulin sensitivity index following a 3-d intervention with a barley kernel-based product: a randomised cross-over study in healthy middle-aged subjects
Nilsson, A. C., Johansson-Boll, E. V., & Björck, I. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002524 · Cited by 109
Type 2 diabetes and gut microbiome: at the intersection of known and unknown
Upadhyaya, S., & Banerjee, G. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1024918 · Cited by 112
Effects of dietary fat on appetite and energy intake in health and obesity — Oral and gastrointestinal sensory contributions
Little, T. J., & Feinle‐Bisset, C. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.038 · Cited by 110
Glucagon‐like Peptide‐2 and the Regulation of Intestinal Growth and Function
Brubaker, P. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170055 · Cited by 132
Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients
Eid, H. M., Wright, M. L., Kumar, N. V. A., Qawasmeh, A., Hassan, S. T. S., Mocan, A., Nabavi, S. M., Rastrelli, L., Atanasov, A. G., & Haddad, P. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00387 · Cited by 110
The Gut Microbiota from Lean and Obese Subjects Contribute Differently to the Fermentation of Arabinogalactan and Inulin
Aguirre, M., de Souza, C. B., & Venema, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159236 · Cited by 101
Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans
Rahat-Rozenbloom, S., Fernandes, J., Cheng, J., & Wolever, T. M. S. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.249 · Cited by 100
Self-citation
Intestinal Sensing of Nutrients
Tolhurst, G., Reimann, F. M., & Gribble, F. M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_14 · Cited by 101
Modulation of Adipocyte Metabolism by Microbial Short-Chain Fatty Acids
May, K. S., & den Hartigh, L. J. (2021) · Nutrients · doi:10.3390/nu13103666 · Cited by 105
Gut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology
May, K. S., & den Hartigh, L. J. (2023) · Nutrients · doi:10.3390/nu15020272 · Cited by 100
Management of metabolic syndrome through probiotic and prebiotic interventions
Grover, S., Mallappa, R., Rokana, N., Duary, R. K., Panwar, H., & Batish, V. K. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91178 · Cited by 101
Gut microbiota alterations and dietary modulation in childhood malnutrition – The role of short chain fatty acids
Pekmez, C. T., Dragsted, L. O., & Brahe, L. K. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.02.014 · Cited by 96
Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications
Gong, M., Wen, S., Nguyen, T., Wang, C., Jin, J., & Zhou, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s232377 · Cited by 95
Prebiotics as functional food ingredients preventing diet-related diseases
Florowska, A., Krygier, K., Florowski, T., & Dłużewska, E. (2016) · Food & Function · doi:10.1039/c5fo01459j · Cited by 92
Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus
Tang, R., & Li, L. (2021) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2021/6632266 · Cited by 96
Short-Chain Fatty Acids in the Microbiota–Gut–Brain Axis: Role in Neurodegenerative Disorders and Viral Infections
Majumdar, A., Venkatesh, I. P. S., & Basu, A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00803 · Cited by 86
Bioactive polysaccharides and oligosaccharides from garlic ( Allium sativum L.): Production, physicochemical and biological properties, and structure–function relationships
Qiu, Z., Qiao, Y., Zhang, B., Sun‐Waterhouse, D., & Zheng, Z. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12972 · Cited by 90
Dietary fibers and their fermented short-chain fatty acids in prevention of human diseases
Prasad, K. N., & Bondy, S. C. (2018) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2018.09.001 · Cited by 87
Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models
Forbes, S. C., Stafford, S., Coope, G., Heffron, H., Real, K., Newman, R., Davenport, R., Barnes, M., Grosse, J., & Cox, H. M. (2015) · Diabetes · doi:10.2337/db15-0481 · Cited by 85
Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study
Pedersen, C., Lefevre, S., Peters, V., Patterson, M., Ghatei, M. A., Morgan, L., & Frost, G. S. (2013) · Appetite · doi:10.1016/j.appet.2013.02.017 · Cited by 83
Interactions of dietary fat with the gut microbiota: Evaluation of mechanisms and metabolic consequences
Mokkala, K., Houttu, N., Cansev, T., & Laitinen, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.05.003 · Cited by 82
A systematic review on gut microbiota in type 2 diabetes mellitus
Chong, S., Lin, M., Chong, D., Jensen, S. O., & Lau, N. S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1486793 · Cited by 107
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
Thulasinathan, B., Suvilesh, K. N., Maram, S., Grossmann, E. M., Ghouri, Y. A., Teixeiro, E., Chan, J., Kaifi, J. T., & Rachagani, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2483780 · Cited by 88
Our extended microbiome: The human-relevant metabolites and biology of fermented foods
Caffrey, E. B., Sonnenburg, J. L., & Devkota, S. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.007 · Cited by 87
Next Generation Microbiome Research: Identification of Keystone Species in the Metabolic Regulation of Host-Gut Microbiota Interplay
Tudela, H., Claus, S. P., & Saleh, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.719072 · Cited by 81
Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes
Zambrowicz, B., Ding, Z., Ogbaa, I., Frazier, K., Banks, P. L., Turnage, A., Freiman, J. P., Smith, M. G., Ruff, D. A., Sands, A., et al. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.01.010 · Cited by 78
Contributions of Colonic Short-Chain Fatty Acid Receptors in Energy Homeostasis
Kuwahara, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00144 · Cited by 75
Short-chain Fatty Acids: A Link Between Prebiotics And Microbiota In Chronic Kidney Disease
Esgalhado, M., Kemp, J. A., Damasceno, N. R. T., Fouque, D. P., & Mafra, D. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0059 · Cited by 73
Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents
Christiansen, C. B., Trammell, S. A. J., Albrechtsen, N. J. W., Schoonjans, K., Albrechtsen, R., Gillum, M. P., Kuhre, R. E., & Holst, J. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00010.2019 · Cited by 69
Intestinal Methanobrevibacter smithii but not total bacteria is related to diet‐induced weight gain in rats
Mathur, R., Kim, G. H., Morales, W., Sung, J. K., Rooks, E., Pokkunuri, V. B., Weitsman, S. R., Barlow, G. M., Chang, C. C.-C., & Pimentel, M. (2013) · Obesity · doi:10.1002/oby.20277 · Cited by 71
Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides
Liu, T., Sun, Z., Yang, Z., & Qiao, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114586 · Cited by 69
Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut
Wang, Y., Leong, L. E. X., Keating, R. L., Kanno, T., Abell, G. C. J., Mobegi, F. M., Choo, J. M., Wesselingh, S. L., Mason, A. J., Burr, L. D., et al. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1534512 · Cited by 65
Short-chain fatty acids as anti-inflammatory agents in overweight and obesity: a systematic review and meta-analysis
Eslick, S., Thompson, C. A., Berthon, B. S., & Wood, L. G. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab059 · Cited by 72
Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation
Xie, C., Jones, K. L., Rayner, C. K., & Wu, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090790 · Cited by 64

Authors: Freeland, K. R., & Wolever, T. M. S.
Affiliations: University of Toronto (CA)
St. Michael's Hospital (CA)
Corresponding author: Wolever, Thomas M. S.
ORCID: Wolever, Thomas M. S.
Venue: British Journal of Nutrition
Publisher: Cambridge University Press (CUP)
Published: 2009-10-12
Volume: 103
Issue: 3
Pages: 460-466
ISSN: 0007-1145 (ISSN-L)
1475-2662
DOI: 10.1017/s0007114509991863
OpenAlex: W1983518876
Cited by: 275
References: 41
Citations by year: 2026: 11 · 2025: 16 · 2024: 18 · 2023: 19 · 2022: 22 · 2021: 24 · 2020: 25 · 2019: 18 · 2018: 20 · 2017: 23 · 2016: 13 · 2015: 13 · 2014: 13 · 2013: 13 · 2012: 14
FWCI: 6.52
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.cambridge.org/core/terms (unspecified)
Locations: British Journal Of Nutrition (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research (64648_1)
Institute of Nutrition, Metabolism and Diabetes
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: short-chain fatty acids, acetate, glucagon-like peptide-1, peptide YY, ghrelin, adiponectin, TNF-α, rectal infusion, intravenous infusion, route of administration, hyperinsulinemia, colonic fermentation, gut-brain axis, weight gain
MeSH terms: Acetates, Administration, Rectal, Adult, Blood Glucose, Female, Humans, Injections, Intravenous, Insulin, Kinetics, Middle Aged, Random Allocation, Tumor Necrosis Factor-alpha, Patient Selection, Cross-Over Studies, Sodium Acetate, Peptide YY, Glucagon-Like Peptide 1, Adiponectin, Ghrelin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks